Chongqing Zhifei Biological Products Co., Ltd.

¥14.91As of Sun 8 Nov 2026, 12:00 UTC
SZSE:300122Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR 2.77%
Div yield —
ROE (62.70%)
Biotechnology
Beta (5Y) 0.40
PE TTM —
TSR TTM (27.59%)
Mkt cap ¥35.69B
ROIC (74.07%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥18
19.20%
(69.68%)
Hold 12|6|10|1|3
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.16
0.17
0.18
0.19
17.26%
18.97%
34.18%
31.57%
Revenue¥B
1.710
1.677
1.681
1.669
0.36%
(1.52%)
0.31%
(2.02%)
Peers (US$5.350B)
Cap (US$)
PE
5.900B
13.54x
4.882B
29.91x
4.719B
—
Capital
TTM
5Y
10Y
Leveragex
0.643
(0.407)
(0.310)
EBIT/Intx
0.300
1.251
1.247
Own earn%
(7.39)
123.37
128.23
Sh yield%
14.66
42.45
36.73
Owners
Insiders/Inst%
14.22
34.47
Short interest%
2.52
SBC / revenue%
2.24
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
13–23
$1 testx
—
Incr. ROIC%
29